A randomized, double-blind, double-dummy, controlled, multicenter study of Qingzhong (tenofovir disoproxil fumarate) versus Viread for the treatment of chronic hepatitis B

Liang, Rong-Yue; Xu, Jing-Hang; Si, Chong-Wen; Wang, Sa; Shang, Jia; Yu, Zu-Jiang; Mao, Qing; Xie, Qing; Zhao, Wei; Li, Jun; Gao, Zhi-Liang; Wu, Shan-Ming; Tang, Hong; Cheng, Jun; Chen, Xin-Yue; Zhang, Wen-Hong; Wang, Hao; Xu, Zhong-Nan; Wang, Ling; Dai, Jun; Yu, Yan-Yan

期刊名称Medicine
作者Liang, Rong-Yue; Xu, Jing-Hang; Si, Chong-Wen; Wang, Sa; Shang, Jia; Yu, Zu-Jiang; Mao, Qing; Xie, Qing; Zhao, Wei; Li, Jun; Gao, Zhi-Liang; Wu, Shan-Ming; Tang, Hong; Cheng, Jun; Chen, Xin-Yue; Zhang, Wen-Hong; Wang, Hao; Xu, Zhong-Nan; Wang, Ling; Dai, Jun; Yu, Yan-Yan
卷第98卷
期第33期
印刷ISSN0025-7974
文件大小268.21KB
发表时间2019-08
DOI10.1097/md.0000000000016778

发现好书期刊，享受阅读乐趣

A randomized, double-blind, double-dummy, controlled, multicenter study of Qingzhong (tenofovir disoproxil fumarate) versus Viread for the treatment of chronic hepatitis B